Generic Name and Formulations:
Clindamycin (as HCl) 75mg+, 150mg+, 300mg; caps; +contains tartrazine.
Indications for CLEOCIN:
Serious susceptible infections where less toxic antibiotics are inappropriate, including respiratory, skin and soft tissue, septicemia, intraabdominal, female pelvic or genital; bone and joint (inj).
Take with full glass of water. Serious: 150–300mg every 6hrs. More severe: 300–450mg every 6hrs. Beta-hemolytic streptococcal infections: treat for at least 10 days.
Take with full glass of water. Serious: 8–16mg/kg per day. More severe: 16–20mg/kg per day. Divide into 3–4 equal doses. Beta-hemolytic streptococcal infections: treat for at least 10 days.
Not for treatment of meningitis. Discontinue if colitis occurs and treat. Permanently discontinue if severe skin reactions occur. Allergy. Asthma (75mg, 150mg caps). GI disease (esp. colitis). Atopy. Monitor blood, renal, and hepatic function in long-term use and in children. Renal or hepatic disease with metabolic aberrations. IV: Gasping syndrome (neonates, infants). Elderly. Pregnancy (Cat.B). Nursing mothers: not recommended.
May potentiate neuromuscular blocking agents. May antagonize erythromycin; avoid. Antiperistaltic agents may worsen colitis.
Pseudomembranous colitis, diarrhea, nausea, vomiting, abdominal pain, rash, anaphylaxis, jaundice, renal dysfunction, blood dyscrasias, polyarthritis, severe skin reactions (eg, toxic epidermal necrolysis, erythema multiforme, Stevens-Johnson syndrome).
Caps—100; Granules (100mL)—1; Inj (2mL, 4mL, 6mL vials)—25
- 150mg capsules (Qty:80)
- appx. price $417.00
- McDonald's and the Microbiome: What Effect Does Junk Food Have on Gut Bacteria?
- When the Doctor is Depressed: One Clinician Tells His Story
- Spice + Statin Likely Culprit in Patient with Acute Hepatitis
- First Non-Surgical Tx for "Double Chin" Gains FDA Approval
- Most Distinctive Causes of Death Mapped by U.S. State
- Heart Rate May Be an Indicator of Future Diabetes Risk
- Probiotic Mixture VSL#3 Shows Promise for Crohn's Recurrence
- Study: Beloranib Appears Safe, Efficacious for Weight Loss in Obesity
- Progress Toward Mind-Controlled Robotic Limbs
- Response to Resistance Exercise Depends on a Person's Genetic Risk for Obesity